Purchase Order N0025919P0191
- Not listed
- This is a federal contract award from the Defense Health Agency to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of Bact/Alert 3D and 3D automated blood culture system supplies and services. The contract has a ceiling value of $11,058.64 and a completion date of October 1, 2024. It is a firm fixed-price purchase order contract with no set-aside designation. Biomerieux Inc., through its Vitek Systems division, has extensive experience providing specialized diagnostic...
- This is a firm-fixed-price purchase order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of VITEK MS-CLINICAL SYSTEM. The contract has a ceiling value of $265,511.00 and a completion date of October 29, 2016. The contract does not have a set-aside designation, as Biomerieux is often the sole source provider for its proprietary technologies. Biomerieux has received numerous federal contracts...
- This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various...
- This is a firm-fixed-price delivery order award to Biomerieux Inc., a global leader in in vitro diagnostics, for $84,478.81. The award is under the Critical Analyzers, Laboratory (FSS-66-III) GSA schedule contract and is for FY18 MICROBIOLOGY VITEK STANDING ORDER requirements from the Bureau of Medicine and Surgery, a component of the Department of Defense. The contract does not have a set-aside designation. Under this order, Biomerieux will provide its proprietary VITEK microbiology analysis...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biomerieux Inc., a foreign-owned for-profit manufacturer of goods. The $100,091.48 contract is for Option #3 under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for VITEK products and services. The contract supports the VA's medical diagnostic testing requirements, providing Biomerieux's proprietary microbiology and molecular biology platforms, reagents, and...
- Biomerieux Inc., operating as Vitek Systems, Inc., received a firm fixed-price delivery order valued at $69.8K from the Bureau of Medicine and Surgery (BUMED), a Defense agency component, for BACT Alert with reagents base plus four option years and BACT Alert FA Plus diagnostic equipment and consumables. The contract was awarded on May 31, 2017, with an ultimate completion date of May 31, 2022, and performance conducted in Eno Valley, NC. This delivery order was issued without a set-aside...
- The federal contract award summarizes a $5,812 firm fixed-price delivery order issued by the Defense Health Agency to Biomerieux Inc., a global leader in in vitro diagnostics. The contract is for the provision of a "MICROBIOLOGY ANALYZER" and does not have a set-aside designation. Biomerieux Inc., through its Vitek Systems, Inc. division, is a key supplier of specialized diagnostic technologies to various government healthcare operations, including the Departments of Veterans...
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency to Biomerieux Inc., doing business as Vitek Systems, Inc., for blood culture maintenance service and a Virtuo Analyzer maintenance agreement. The total ceiling value of the contract is $71,593.20, with a completion date of June 24, 2026. The contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics and microbiological testing solutions, specializing in manufacturing...
- This federal contract award is a purchase order issued by the Defense Health Agency to Biomerieux Inc., a global leader in in vitro diagnostics. The award, valued at $59,724.85, is to pay Claim 25-001 under a previous contract (W91YTZ-23-C-0015) for an invoice in that amount. The contract is a firm-fixed price purchase order with a completion date of March 10, 2025. Biomerieux Inc., through its Vitek Systems, Inc. division, is a critical supplier of specialized diagnostic technologies to various...
- This contract was awarded by the Defense Health Agency, a defense agency, to Biomerieux Inc., a for-profit manufacturer of medical diagnostic equipment and reagents. The $17,658.76 firm fixed-price purchase order is for a full-service plan, with an ultimate completion date of April 1, 2023. The contract does not have a set-aside designation. Biomerieux Inc., through its Vitek Systems, Inc. division, has been awarded numerous federal contracts and Indefinite Delivery Vehicles (IDVs) by agencies...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Biomerieux Inc., doing business as Vitek Systems, Inc. The contract provides a full service plan for one Bact Alert blood culture analyzer, with a base year and four option years. The total potential value of the contract is $19,224.24. This contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics and microbiological testing solutions, specializing in manufacturing advanced diagnostic equipment, reagents, and test kits for government healthcare agencies. The contract award is likely part of Biomerieux's broader portfolio of federal contracts and indefinite delivery vehicles with agencies such as the Department of Veterans Affairs and Indian Health Service, focused on providing specialized diagnostic technologies and laboratory services to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 6/23/20 | |
| P00001 | Exercise an Option | $3.8k | 2/13/20 | |
| Not listed | Not listed | $3.8k | 2/28/19 |